Abstract
This single-arm multicenter Phase II study investigated the efficacy and safety of pemetrexed (Pem) and cisplatin (Cis) induction chemotherapy (CT) followed by full-dose Pem-Cis plus concurrent radiotherapy (RT) in patients with locally advanced non-squamous NSCLC. Patients with unresectable Stage III non-squamous NSCLC received two 21-day cycles of Pem 500 mg/m(2) (vitamin/folic acid supplementation and dexamethasone prophylaxis per Pem-label)+Cis 75 mg/m(2) on Day 1. Eligible patients who had not progressed continued with 2 further cycles of full-dose Pem-Cis plus concurrent RT (2 Gy/fraction, 5 days/week, 66 Gy total). Primary endpoint was the 1-year progression-free survival (PFS) rate. Of 90 patients enrolled (all treated; median age 61 years, male/female 57%/43%, ECOG performance status 0/1 66%/34%, adenocarcinoma 90%, Stage III 36%/62%), 75 (83%) completed induction CT and started concurrent CT+RT. 64 (71%) patients received all 4 CT cycles and an RT dose ≥60 Gy. The 1-year PFS rate was 51.3% (95%CI: 42.0, 60.5). Median PFS was 10.6 months (95%CI: 8.6, 17.3), median OS was 26.2 months (95%CI: 16.7, not estimable). One patient died from enteritis (treatment-related) during Cycle 4. Four patients discontinued due to treatm...Continue Reading
References
May 6, 2003·Circulation Research·Georgina CollettAnn E Canfield
Apr 4, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Everett E VokesUNKNOWN Cancer and Leukemia Group B
May 29, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giorgio Vittorio ScagliottiDavid Gandara
Mar 10, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hui TangDaniel J Sargent
Mar 31, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anne AupérinJean-Pierre Pignon
Jul 8, 2010·International Journal of Radiation Oncology, Biology, Physics·Anthony BradeFrances A Shepherd
Dec 18, 2010·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Renaud DescourtUNKNOWN GFPC VINCR Team
Mar 19, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Shirish M GadgeelAndrew Turrisi
Sep 10, 2011·Journal of the National Cancer Institute·Walter J CurranJames D Cox
Jan 13, 2012·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Jan 22, 2013·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Françoise MornexJean-Marc Tourani
Apr 25, 2013·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Pilar GarridoBartomeu Massutí
Jul 19, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J VansteenkisteUNKNOWN ESMO Guidelines Working Group
Aug 29, 2013·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Hak ChoyColeman Obasaju
Aug 5, 2014·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·G V ScagliottiL G Paz-Ares
Citations
Oct 9, 2016·BMC Cancer·Yiyu LuWen Yang
Apr 10, 2012·Seminars in Oncology·Ronald C DeConti
Nov 14, 2016·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Nancy L OleinickMitchell Machtay
Aug 2, 2017·ESMO Open·Pilar GarridoSilvia Novello
Jun 22, 2018·American Journal of Therapeutics·Daniel Chapman, Asma Taj
Apr 30, 2019·BioMed Research International·Baishen ChenXiangfeng Gan